Asociación entre títulos de anticuerpos anticardiolipinas y eventos trombóticos

Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x Cervera, 2002, Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients, Arthritis Rheum, 46, 1019, 10.1002/art.10187 Wisloff, 2002, Laboratory diagnosis of the antiphospholipid syndrome, Thromb Res, 108, 263, 10.1016/S0049-3848(02)00400-0 1993, The Antiphospholipid Antibodies in Stroke Study (APASS) Group, Neurology, 43, 2069 Levine, 1997, IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study, Stroke, 28, 1660, 10.1161/01.STR.28.9.1660 Levine, 2004, Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke, Jama, 291, 576, 10.1001/jama.291.5.576 Turiel, 2005, Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study, Stroke, 36, 1490, 10.1161/01.STR.0000170645.40562.09 Ginsberg, 1995, Antiphospholipid antibodies and venous thromboembolism, Blood, 86, 3685, 10.1182/blood.V86.10.3685.bloodjournal86103685 Oger, 1997, Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus, Lupus, 6, 455, 10.1177/096120339700600508 Naess, 2006, A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study), J Thromb Haemost, 4, 44, 10.1111/j.1538-7836.2005.01691.x Urbanus, 2009, Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study, Lancet Neurol, 8, 998, 10.1016/S1474-4422(09)70239-X Hudson, 2003, The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies, J Rheumatol, 30, 2385 Baker, 2008, Controversies and Unresolved Issues in Antiphospholipid Syndrome Pathogenesis and Management, Hematol Oncol Clin North Am, 22, 155, 10.1016/j.hoc.2007.10.006 Giron-Gonzalez, 2004, Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals, J Rheumatol, 1560 Vargas, 2006, Síndrome Antifosfolípido: morbilidad y evolución de una cohorte de pacientes del Hospital Pablo Tobón Uribe de Medellín-Colombia, Revista Colombiana de Reumatología, 13, 109 Finazzi, 1996, Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry, Am J Med, 100, 530, 10.1016/S0002-9343(96)00060-5 Marai, 2001, Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population, Harefuah, 140, 495 Musial, 2003, Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis, J Rheumatol, 30, 723 Sairam, 2003, Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies, Clin Rheumatol, 22, 24, 10.1007/s10067-002-0660-7 Ruffatti, 2009, Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study, Ann Rheum Dis, 68, 397, 10.1136/ard.2008.096669 Amin, 2008, Antiphospholipid syndromes in infectious diseases, Hematol Oncol Clin North Am, 22, 131, 10.1016/j.hoc.2007.10.001 Sene, 2008, Antiphospholipid antibodies, antiphospholipid syndrome and infections, Autoimmun Rev, 7, 272, 10.1016/j.autrev.2007.10.001 Afeltra, 2005, Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors, Arthritis Rheum, 53, 452, 10.1002/art.21172 Torres, 2006, Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population, Am J Hematol, 81, 933, 10.1002/ajh.20733 Miesbach, 2008, Neurologic symptoms as a feature of the antiphospholipid syndrome, Semin Thromb Hemost, 34, 286, 10.1055/s-0028-1082273 Tellez-Zenteno, 2001, Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases, Lupus, 10, 851, 10.1191/096120301701548490 Lu, 2008, Prognostic factors of lupus myelopathy, Lupus, 17, 323, 10.1177/0961203307088005 D’Cruz, 2004, Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies, J Rheumatol, 31, 280